Potent antimalarial 2-Pyrazolyl Quinolone bc 1 (Qi) inhibitors with improved drug-like properties
A series of 2-pyrazolyl quinolones has been designed and synthesized in 5-7 steps to optimize for both in vitro antimalarial potency and various in vitro drug metabolism and pharmacokinetics (DMPK) features. The most potent compounds display no cross-resistance with multidrug resistant parasite stra...
Egile Nagusiak: | Hong, W, Leung, SC, Amporndanai, K, Davies, J, Priestley, RS, Nixon, GL, Berry, NG, Hasnain, S, Antonyuk, S, Ward, SA, Biagini, GA, O'Neill, PM |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
American Chemical Society
2018
|
Antzeko izenburuak
-
Targeting the Ubiquinol-Reduction (Q<sub>i</sub>) Site of the Mitochondrial Cytochrome <i>bc<sub>1</sub></i> Complex for the Development of Next Generation Quinolone Antimalarials
nork: Kangsa Amporndanai, et al.
Argitaratua: (2022-07-01) -
Antimalarial activity of primaquine operates via a two-step biochemical relay
nork: Camarda, G, et al.
Argitaratua: (2019) -
X-ray and cryo-EM structures of inhibitor-bound cytochrome bc1 complexes for structure-based drug discovery
nork: Kangsa Amporndanai, et al.
Argitaratua: (2018-03-01) -
Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria.
nork: Biagini, G, et al.
Argitaratua: (2012) -
Quinolone-3-diarylethers: a new class of antimalarial drug.
nork: Nilsen, A, et al.
Argitaratua: (2013)